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Interleukin-10 (IL-10) is considered to be a cytokine with potent anti-inﬂammatory properties, which have been previously
linked to increased incidence of sepsis. The level of IL-10 is elevated by cardiac surgery when cardiopulmonary bypass (CPB) and
methylprednisolone are used. In our study, we compare the level of IL-10, IL-10 Receptor (IL-10R), and percentage of neutrophils
between two groups of cardiac surgical patients undergoing Coronary Artery Bypass Grafting, both of which were not given
methylprednisolone. The ﬁrst group was operated with conventional CPB, while the second group was operated with minimally
invasive CPB (mini-CPB).We detected enhanced level of IL-10 during surgery and at the end of surgery in both groups of patients.
While no correlation between IL-10 and IL10R was found, IL-10 was positively correlated with increased percentage of neutrophils
at the time points when the level of IL-10 peaked.
1.Introduction
Cardiac surgery is connected to profound inﬂammatory
response, characterized by increased level of both proinﬂam-
matoryandanti-inﬂammatorymediators.Cardiopulmonary
bypass(CPB)isconsideredtobeapotentialtriggerofcytoki-
nerelease,therefore,theimpactofcardiacsurgeryonmorbi-
dity and mortality is often correlated with the use of CPB [1,
2].SurgeryconductedwiththeuseofCPBisaccompaniedby
ischemia-reperfusion injury, and above that, CPB also repre-
sents the environment where blood cells become activated
by contact with artiﬁcial surfaces, direct air-contact, and also
nonturbulentﬂow.Theeﬀorttoremovetheharmfuleﬀectof
conventional CPB has led to a development of new surgical
devices and techniques. Mini-CPB, that has recently been
introducedandsuccessfullyused,isdesignedtoreduceblood
cell activation: it provides decreased area of extracorporeal
circuit, reduces priming, and also lessens air-blood interface.
Another favorable feature of mini-CPB is a biocompatible
coating that induces higher tolerance by blood cells. The im-
pact of mini-CPB on suppressing inﬂammatory response is
already described and published [3, 4].
As the blood reaches all the body compartments, inﬂam-
matory response to surgical injury exceeds local reaction
and becomes systemic. Although the increased production
of cytokines is essential for protection against infection and
alsohealingthewounds,unregulatedinﬂammatoryresponse
is likely to have a harmful eﬀect. Regulating mechanisms
consist of anti-inﬂammatory molecules such as cytokines,
cellsurfaceenzymes,receptorantagonists,andsolublerecep-
tors [5]. The net impact of the produced cytokines, whether
with proinﬂammatory or anti-inﬂammatory properties, is
determined by the ability of the immune system to balance
the inﬂammatory response properly [6].
IL-10 is a regulatory and immunosuppressive cytokine
that is produced by a variety of cells [7]. Upon binding to
its receptor (IL-10R), IL-10RB subunit transmits a signal
into the cell which activates STAT3- and STAT3-resposive2 Mediators of Inﬂammation
Table 1: Demographic and preoperative data.
Conventional CPB Mini-CPB P value
Patients (no.) 22 22
Women/men (no.) 4/18 2/20 0.66
Age (years) 68 (63–71) 69 (66–74) 0.57
Body mass index 28.5 (25.3–32) 26.5 (25–31.3) 0.38
Acetylsalicylic acid (no.) 21 21
Beta blockers (no.) 21 20
ACE inhibitors (no.) 16 18 0.72
Statins (no.) 21 20
Diabetes mellitus (no.) 4 6 0.72
COPD (no.) 3 4
Prior myocardial infarction (no.) 12 9 0.37
Leukocytes (cells ×109/L) 7.5 (6.8–8.5) 7.1 (6.3–8.8) 0.8
Ejection fraction (%) 64.5 (51.3–69.8) 60 (48.5–69.5) 0.35
Parametersmarkedas“no.”displaythenumberofpositivecasesinagroupofpatientsornumberofpatientstreatedwithagivenmedication.Otherparameters
are characterized by median value and interquartile range in brackets. If both groups contain the same number of cases or if they unequal by a case, then
P-value is above 0.99 and is not displayed. ACE: angiotensin-converting enzyme; COPD: chronic obstructive pulmonary disease.
genes [8]. As a result, the production of proinﬂammatory
cytokines, such as IL-1 and TNF-α, is inhibited [9].
The changes in production of IL-10, IL-1, and TNF-α
have already been extensively evaluated in patients undergo-
ingCABGsurgerywithconventionalCPB[10].However,the
information about kinetics of IL-10 in mini-CPB patients is
sparse. We compared the changes of IL-10 serum level, the
expression of IL-10 membrane receptor, and the percentage
of neutrophils in conventional and mini-CPB patients, as
well as between these groups of patients. We also examined
the incidence of sepsis and acute renal dysfunction in both
groups.
2.MaterialandMethods
2.1. Patients. Forty-four patients, undergoing elective coro-
nary artery bypass grafting (CABG) surgery on an arrested
heart using CPB, were enrolled into our study. All patients
were well informed about the purpose of the study and they
conﬁrmed their unconstrained participation by a written
consent. The study project was approved by the Ethics
Committee of the University Hospital in Hradec Kralove,
Czech Republic. Patients, included in the study group
in the period from December 2006 to December 2007,
were randomly assigned to surgery either with the use of
conventional CPB (n = 22)ormini-CPB(n = 22).Exclusion
criteria consisted of acute inﬂammation, urgent operation,
reoperation, combined operations, operative risk more than
5% (according to logistic Euroscore), preoperative level of
serum creatinine above 130μmol/L, hepatic disease, and
malignancies.Thedemographicandpreoperativedataofour
patients are shown in Table 1.
2.2. Conventional Cardiopulmonary Bypass (CPB). CPB was
established using a two-stage venous drainage and ascending
aortic return. A roller pump (St¨ ockert Instrumente GmBH,
M¨ unchen, Germany), a membrane oxygenator (Dideco SrL,
Mirandola, Italy) in a closed modiﬁcation with a collapsible
reservoir, a cardiotomy suction device, and a 40μma r t e r i a l
line ﬁlter (Dideco SrL, Mirandola, Italy) were integrated
into the extracorporeal circuit. The system surface was not
treated with any hemocompatible substance. The priming
solution consisted of 500mL of Ringer’s lactate, 500mL
of Rheodextran (Rheomacrodex), 5,000IU heparin, 80mL
of Natrium Bicarbonate (NaHCO3 8,4%), 20mL of 10%
Magnesium Sulphate, and Mannitol (at 1g/kg body weight).
The priming volume was calculated so that hematocrit level
reached above 0.22. Heparin was administered intravenously
at 300IU/kg body weight to maintain an activated clotting
time (ACT) above 480s during bypass procedure. Patients
received neither aprotinin nor corticosteroids intravenously.
Pump ﬂow rates averaged 2.4L/min/m2 of body surface
area with pressure maintained at 50–60mmHg. The patients
were kept normothermic. Cardioplegic arrest was induced
with a cold blood cardioplegic solution, which consisted
of blood mixed with St. Thomas solution (Ardeapharma,
Sevetin, Czech Republic) in 4:1 ratio. It was administered
antegradely into the aortic root with doses added every
20min or as needed. All patients received an internal artery
mammary graft to the left anterior descending coronary
artery.Thecentralaortovenousanastomoseswereperformed
during the reperfusion phase of cardiopulmonary bypass
withtheheartbeating.AftertheterminationofCPB,heparin
anticoagulation was antagonized using Protamine Sulphate
at a dose of 1:1.
2.3. Minimally Invasive Cardiopulmonary Bypass (Mini-
CPB). Mini-CPB was established using a small 22F two-
stage venous drainage and ascending aortic return. Minisys-
tem Synergy (Sorin Group SrL, Mirandola, Italy) consisted
of a centrifugal pump, membrane oxygenator, 40μma r t e r i a l
line ﬁlter, and a venous bubble trap. Cardiotomy suction
was not used. The whole system, consisting of a closed loop
with the surface treated with PH.I.S.I.O phosphorylcholineMediators of Inﬂammation 3
coating (Sorin Group SrL, Mirandola, Italy) and very short
tubing, was placed close to the operating ﬁeld. The prim-
ing solution, heparinization, pump ﬂow, temperature, and
surgery technique were identical with the conventional CPB
procedure described above. Cardioplegic arrest, induced
according to the Calaﬁore warm blood-cardioplegia proto-
col, was administered antegradely into the aortic root. At the
beginning of CPB, crystalloid priming solution was ﬂush-
ed retrogradely together with the blood coming from the
arterial line to minimize the hemodilution of the patient.
2.4. Anesthesiological Management. All patients were anes-
thetized according to the current protocol of our depart-
ment.AnesthesiawasinducedusingThiopentalandMidazo-
lam. Muscular relaxation was achieved with Cisatracurium.
Anesthesia was maintained with Isoﬂurane and intermittent
use of Sufentanyl. Continuous infusion of Propofol was used
as a supplement if needed. Volume-controlled ventilation
with FiO2 0.5 was employed. Mean arterial pressure was
kept above 50mmHg, with norepinephrine administered as
required.
2.5. Sample Collection and Data Acquisition. Blood samples
were withdrawn from subclavian vein before and during sur-
gery and from antebrachial vein in postsurgery period. The
samples were collected into anticoagulant-untreated Vacu-
tainer tubes as well as heparinized Vacutainer tubes (Becton
Dickinson, UK) at the following time points: before surgery
(introduction of anesthesia), at the beginning of CPB, at
termination of CPB, at the end of surgery, and on the 1st,
3rd, and 7th postoperative day.
Serum was separated from the blood cells by centrifuga-
tionat1000gfor15min.Sampleswerestoredat −80◦Cprior
to analysis. IL-10 concentration was determined by enzyme-
linked immunosorbent assay (ELISA), with a sensitivity of
1pg/mL. ELISA kit was purchased from Bender MedSystems
(Austria). IL-10 concentrations were measured using spec-
trophotometer (Labsystems Multiskan RC, USA) with Gene-
sis software.
Heparinized blood samples were processed immediately
after collection. 50μL of blood was incubated with titrated
monoclonal antibodies anti-CD3 FITC/IL-10R PE/CD14
PerCP/CD16 APC. Antibodies, except for anti-IL-10R, were
purchased from BD Biosciences (USA), while anti-IL-10R
was purchased from BioLegend, USA. Following the 20min
incubation, red blood cells were lysed by hypotonic lysis and
then the samples were washed. The data acquisition was per-
formed with FACS Calibur ﬂow cytometer using CellQuest
software (BD Biosciences, USA), and the analysis was done
using FlowJo software (Tree Star, USA). Expression of IL-
10R on cells was displayed as median ﬂuorescence intensity
(MFI).ExpressionofIL-10Rduringsurgerywasnotassessed.
2.6.StatisticalAnalysis. ValuesofIL-10,IL-10R,andpercent-
age of neutrophils during and after surgery were compared
to preoperative values. Normal distribution of the data was
determined by Shapiro-Wilk test. Changes within a group
were evaluated using ANOVA for repeated measures and
Dunnett’s test or Friedman ANOVA and Wilcoxon paired
test. To determine the diﬀerences between both groups of
patients, values of IL-10, IL-10R, and percentage of neutro-
phils were compared at matching time points using two-
way ANOVA for repeated measures and Fisher’s LSD test or
Mann-Whitney U test. The relationship between IL-10 and
percentage of neutrophils was assessed by Spearman correla-
tion coeﬃcient. Demographic and clinical data were ana-
lyzed by Fisher exact test, Mann-Whitney U test, and
Student’s t-test. All tests were performed at a signiﬁcance
levelof0.05.Bonferronicorrectionwasusedincaseofmulti-
ple comparisons. Results of statistical analysis were expressed
as medians unless stated otherwise.
3. Results
3.1.DiﬀerencesinIL-10inSerumwithintheGroups. Changes
in IL-10 serum level were similar in both groups of patients,
with respect to the preoperative serum level of 1pg/mL
in conventional CPB group and 1.45pg/mL in mini-CPB
group. In the conventional CPB group, serum level of
IL-10 signiﬁcantly increased at the termination of CPB
(52.7pg/mL, P<0.001), at the end of surgery (50.5pg/mL,
P<0.001), and on the 1st postoperative day (7.3pg/mL, P<
0.01).Similarly,themini-CPBgroupexperiencedanincrease
in serum level at the termination of CPB (from 1.5pg/mL to
10.6pg/mL, P<0.01), at the end of surgery (21.2pg/mL,
P<0.001), and on the 1st postoperative day (5.8pg/mL, P<
0.05). Postsurgery monitoring revealed that the level of IL-
10 was gradually decreasing in both groups and did not sig-
niﬁcantly diﬀer from preoperative levels (Figure 1).
3.2. Diﬀerences in IL-10 in Serum between the Groups. There
was signiﬁcant serum-level diﬀerence (P<0.01) between
both groups at the termination of CPB: the conventional
CPB group topped the mini-CPB group by reaching the
value of 52.7pg/mL. At this time point, IL-10 in mini-CPB
group was enhanced, but only reached 10.6pg/mL. In mini-
CPB group, the level of IL-10 was highest at the end of sur-
gery (21.2pg/mL). In postsurgery period, the level of IL-10
decreased and did not diﬀer between both groups (Figure 1).
3.3. Percentage of Neutrophils. Percentage of neutrophils was
signiﬁcantly increased (P<0.001) in both groups of patients
at the end of CPB, at the end of surgery, and also on the 1st
and 3rd postoperative day. The baseline was 55% of neutro-
phils in conventional CPB group and 53% in mini-CPB
group. The highest percentage of neutrophils was measured
on the 1st postoperative day in both groups of patients (80%
in conventional CPB group and 81% in mini-CPB group).
There was statistically signiﬁcant diﬀerence in percentage
of neutrophils between both groups at the end of surgery
(P<0.05) when conventional CPB group reached 79% and
mini-CPB group reached 75% of neutrophils (Figure 2).
The percentage of neutrophils correlated with the max-
imum level of IL-10 at the termination of CPB (rs = 0.73,
P<0.001), at the end of surgery in conventional CPB group4 Mediators of Inﬂammation
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Figure 1: IL-10 level in serum of patients operated either with
conventional CPB or mini-CPB. The IL-10 level was detected by
ELISA. The level of IL-10 diﬀered between conventional CPB and
mini-CPB group after termination of CPB (P<0.01). Even though
the diﬀerence at the end of surgery was not statistically signiﬁcant,
IL-10 greatly varied when comparing both groups. Squares display
median,boxesarequartiles,andwhiskersdisplaytherangeofnono-
utlier values.
(rs = 0.54, P<0.01), and at the end of surgery in mini-CPB
group (rs = 0.54, P<0.01) (Figures 3(a)–3(c)).
3.4. Expression of IL-10 Receptor (IL-10R). Since IL-10R is
expressed on T lymphocytes, neutrophils, and monocytes,
the expression was statistically evaluated in all of these popu-
lations. In lymphocytes and neutrophils, no diﬀerences were
found at any time point when comparing MFI values within
a group of patients or between both groups of patients.
The expression of IL-10R on monocytes signiﬁcantly de-
creasedattheendofsurgeryinbothgroups:thepreoperative
expression of IL-10R dropped from MFI of 10.2 to 7.6 (P<
0.01) in conventional CPB group, as well as in mini-CPB,
where the preoperative level dropped from MFI of 9.8 to 7.6
(P<0.05). On the 3rd postoperative day, the expression of
IL-10R on monocytes was signiﬁcantly enhanced (Figure 4),
reaching MFI of 10.6 in conventional CPB (P<0.05)
and 11.3 in mini-CPB (P<0.05). After that, the IL-10R
expression decreased again and there was no signiﬁcant
diﬀerence between the preoperative value and the value on
the 7th day after surgery in both groups (Figure 5).
There was no correlation between serum level of IL-10
and expression of IL-10R on monocytes.
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Figure 2: Percentage of neutrophils in peripheral blood samples
of patients with conventional CPB or mini-CPB. The percentage
of neutrophils was evaluated by ﬂow cytometry. The percentage of
neutrophilssigniﬁcantlydiﬀeredbetweenbothgroupsofpatientsat
the end of surgery (79% of neutrophils in conventional CPB group
versus 75% of neutrophils in mini-CPB group, P<0.05). Squares
display, median, boxes are quartiles, and whiskers display the range
of nonoutlier values.
No diﬀerence in IL-10R expression on monocytes
was observed when comparing both groups of patients
(Figure 5).
We observed single- as well as multiple-organ dysfunc-
tion or failure in both groups of patients. IL-10 level in each
g r o u pi sl i s t e di nTable 2. Only two patients were considered
suﬀering from sepsis. Intraoperative and postoperative data
of patients are displayed in Table 3.
4. Discussion
IL-10 is an important cytokine, maintaining the proinﬂam-
matory response balanced. Although IL-10 can keep cells
unresponsive, receptors on the cells aﬀected by IL-10 are still
capable of binding and internalizing proinﬂammatory cyto-
kines. As a result, the cytokines are removed from blood cir-
culation without subsequent activation of the cells [11, 12].
This kind of decoy activity is thought to be of favorable con-
tribution of IL-10 in ischemic heart after myocardial reper-
fusion, and it is likely to prevent against heart failure [13].
However, high level of IL-10 can also have an adverse eﬀect
by increasing the likelihood of sepsis. Nonetheless, a sig-
niﬁcant association between sepsis and higher level of IL-10
determined by—1082 base pair single polymorphism in pro-
moter region of IL-10 gene is equivocal [14, 15]. It has beenMediators of Inﬂammation 5
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Figure 3: Relationship between percentage of neutrophils and serum level of IL-10. (a) Correlation, rs = 0.73, in conventional CPB group at
the termination of CPB (P<0.001). (b) Correlation, rs = 0.54, in conventional CPB group at the end of surgery (P<0.01). (c) Correlation,
rs = 0.54, in mini-CPB group at the end of surgery (P<0.01)
Table 2: IL-10 level in groups of patients without and with organ dysfunction or failure.
No organ aﬀected
(n = 15)
One and more organs
aﬀected (n = 7)
One organ aﬀected
(n = 5)
More organs aﬀected
(n = 2)
Conventional CPB (n = 22) 89 (41−451) 203 (148−731) 181 (148–385) 467 (203−731)
No organ aﬀected
(n = 11)
One and more organs
aﬀected (n = 11)
One organ aﬀected
(n = 6)
More organs aﬀected
(n = 5)
MINI-CPB (n = 22) 35 (13−219) 75 (23−192) 105 (23–183) 55 (49–192)
Groups of patients were divided by number of organs suﬀering from dysfunction or failure. Upper value displays median of IL-10 (pg/mL), values in the
brackets describe the range from minimum to maximum characterizing a group.
reported that CPB induces the release of IL-10, which can
be further enhanced by the use of corticosteroids in pa-
tients undergoing CABG [16]. In our study, corticosteroids
were not applied, and yet we observed that CPB induced a
profound release of IL-10. We found signiﬁcant diﬀerence
in IL-10 production between the two diﬀerent types of CPB
used. Mini-CPB, which is considered to be a less harmful ap-
proach of cardiac surgery, elicited a lower release of IL-10.
In spite of this fact, the increase of IL-10 does not seem to
impact clinical outcome. Although the level of IL-10 was
lower in mini-CPB group, the number of patients suﬀer-
ing from organ dysfunction or failure was nonsigniﬁcantly
higher in mini-CPB group than in conventional CPB group
(P<0.22)(Table 2).Whilewewouldbeabletopredictorgan
dysfunction or failure according to IL-10 level in conven-
tional CPB group, the similar relation was unclear in mini-
CPB group. We also looked at the IL-10 value in patients
with sepsis and patients without sepsis. Microbiologically
conﬁrmed, there were only two septic patients, one in each
group,both reachingvaluesof IL-10in serumthatfellwithin
quartiles of IL-10 calculated for each sampling time point in
anygivengroup.Therefore,inourstudygroups,eventhough
the IL-10 level was very high in some patients, IL-10 could
not be used as a predictive marker related to sepsis. Increased
level of IL-10 along with the medical treatment (Ampicillin-
sulbactam) of our patients might have prevented the onset of6 Mediators of Inﬂammation
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Figure 4: Illustration of changes in the expression of IL-10R on monocytes of conventional CPB patient. Monocytes are discriminated
from other populations of cells by high expression of CD14 (x-axis). (a) Leukocytes before surgery. (b) Leukocytes on the 3rd postoperative
day. (c) Overlaid histograms of monocytes from (a) and (b). Although the expression of IL-10R on monocytes enhances on the 3rd day
after surgery (black line), it is relatively weak considering the isotype control (dark grey line). Intracellular staining did not reveal higher
expression of IL-10R in cells (data is not shown).
sepsis. Such a beneﬁcial role of IL-10 is in concordance with
experimental studies [17, 18].
Inpreviousworks,IL-10levelwasalsofoundtobesignif-
icantlyincreased in patients who suﬀered from postoperative
renaldysfunction[19],whichwascharacterizedbycreatinine
levelraisedabove176μmol/L[20].Themini-CPBgrouphad
two patients that were suﬀering from acute renal dysfunc-
tion, while there was only one patient in conventional CPB
group. The patient from conventional CPB group reached
522.5pg/mL at the termination of CPB. This patient had the
highest value of IL-10 in serum out of both groups. How-
ever, the other two patients did not exceed quartiles of IL-
10 calculated for each sampling time point. According to this
result, there is no simple relation between enhanced level of
IL-10 and increased probability of acute renal dysfunction.
WecomparedthepercentageofneutrophilstoIL-10level
when IL-10 in serum was at its highest level. We observed
signiﬁcant correlation between IL-10 and percentage ofMediators of Inﬂammation 7
Table 3: Intraoperative and postoperative data of patients.
Conventional CPB Mini-CPB P value
Duration of surgery (min) 210 (161–250) 165 (155–203) 0.15
Duration of CPB (min) 70 (56–111) 62 (55–76) >0.1
Priming solution (mL) 1600 (1425–1800) 1100 (1000–1300) <0.001
Anastomoses (no.) 2 (2-3) 2 (2-3) 0.7
Intraoperative blood loss (mL) 1000 (725–1000) 700 (500–950) 0.14
Postoperative blood loss in 24h (mL) 650 (450–1075) 600 (500–950) >0.1
Acute renal dysfunction and failure (no.) 1 2
Respiratory dysfunction and failure (no.) 4 9 0.19
Postsurgery myocardial dysfunction and AMI (no.) 5 6
Sepsis (no.) 1 1
Parameters marked as “no.” display the number of positive cases in a group of patients with the exception for number of anastomoses which denotes median
value. All other parameters are characterized by median value and interquartile range in brackets. If both groups contain the same number of cases or if they
unequal by a case, then P-value is above 0.99 and is not displayed. AMI: acute myocardial infarction.
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Figure 5: Expression of IL-10R on monocytes in peripheral blood
samples of conventional CPB or mini-CPB group as a result of ﬂow
cytometry data analysis. The expression of IL-10R did not signiﬁ-
cantly diﬀer between both groups of patients. Squares display med-
ian,boxesarequartiles,andwhiskersdisplaytherangeofnonoutlier
values.
neutrophils at the termination of CPB in conventional CPB
group (rs = 0.73, P<0.001) and at the end of surgery
in mini-CPB group (rs = 0.54, P<0.01). We also found
lower—but still signiﬁcant—correlation (rs = 0.54, P<
0.01) between IL-10 and percentage of neutrophils at the
second highest level of IL-10 (at the end of surgery) in con-
ventional CPB group. Our data suggests that neutrophils
were the main producers of IL-10 in most of our cardiac sur-
gical patients. However, the lower correlation coeﬃcient at
the end of surgery indicates other cells might also have
participated in IL-10 production. The observation is in
agreement with recently published ﬁndings that show that
neutrophils are an important source of IL-10 [21]a n d
that mini-CPB attenuates neutrophil activation and cytokine
release after coronary bypass surgery [3].
IL-10 exerts its function through the binding to IL-10R
[22]. It seems that higher level of IL-10 in conventional
CPB group is exclusively linked to the surgery technique
and devices used. Since we found no signiﬁcant diﬀerence in
expressionofIL-10Rbetweenbothgroupsofpatients,wecan
hypothesize that the expression of IL-10R on hematopoietic
cells exceeds the maximum level of its ligand, IL-10. It has
been discovered that other cells, such as ﬁbroblasts and
epithelial cells [23, 24], also express IL-10RA after induction;
thus IL-10 may have a much broader eﬀect on tissues and
organs, an eﬀect which cannot be explained by the possible
correlation of serum IL-10 and the expression of IL-10R on
monocytes.
5. Conclusion
IL-10 level and percentage of neutrophils are signiﬁcantly
aﬀected by the type of cardiac surgery employed. Although
IL-10 level may have statistical relation to sepsis or renal
dysfunction, the generally accepted critical level that would
enable to unambiguously distinguish between patients with
worse or good prognosis does not exist. However, in certain
conditions,likeusingconventionalCPB,IL-10mayrepresent
a supporting tool, that, along with other parameters, would
help rank the patients in likelihood of organ dysfunction or
failure. The observed correlation between increased level of
IL-10 and higher percentage of neutrophils in both groups of
patients suggests functional relationship between both para-
meters.
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